Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequencing Vyvanse and Behavioral Parent Training for Mothers with ADHD (TMF)
NCT01816074Phase 4Completed
- Sponsor
- Seattle Children's
- Start
- Oct 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Seattle Children's. Started Oct 2012; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01816074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01816074.